Evidence mapPaperPMID 41897407Full record

ArticleBiomolecules2026

The Role of Cholesterol at the CHOL2 Site and the Dimeric Interface in the Regulation of Serotonin Transporter Function and Dimerization.

Jian Yang, Chan Li, Xingyu Huang, Yuan-Wei Zhang

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jian YangSchool of Life Sciences, Guangzhou University, Guangzhou 510006, China.
Chan LiSchool of Life Sciences, Guangzhou University, Guangzhou 510006, China.ORCID 0000-0002-0623-7450
Xingyu HuangSchool of Life Sciences, Guangzhou University, Guangzhou 510006, China.ORCID 0009-0006-8782-699X
Yuan-Wei ZhangSchool of Life Sciences, Guangzhou University, Guangzhou 510006, China.ORCID 0000-0002-4276-9251

Funding

National Natural Science Foundation of China 32071233National Natural Science Foundation of China 32371304
6 · The paper itself

Abstract

Serotonin transporter (SERT) precisely regulates serotonin (5-HT) signaling in the central nervous system and is a major target of antidepressants for the treatment of major depressive disorder. Despite significant progress in characterizing its structure and transport mechanism, the regulation of SERT function by various modulators remains to be fully understood. In the present study, we focused on two potential cholesterol sites in human SERT to investigate cholesterol occupation at these sites and its functional relevance by biochemical approaches. Mutations of an intramolecular site (CHOL2) significantly decreased both specific transport activity and

Indexed as

CholesterolSerotonin Plasma Membrane Transport ProteinsBinding SitesHumansMutationProtein ConformationProtein MultimerizationSerotoninCholesterolSerotoninSerotonin Plasma Membrane Transport Proteinscholesterolconformationdimerizationregulationserotonin transportertransport function

Identifiers

PMID41897407
PMCPMC13024735

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.